UPDATE 1-Halozyme suspends pancreatic cancer study, shares plunge

April 4 (Reuters) - Halozyme Therapeutics Inc said it had halted enrolment of patients and dosing of its cancer drug in a mid-stage trial for the treatment of pancreatic cancer, after the...

from Reuters: Hot Stocks http://ift.tt/1hIUuet